EquityZen Growth Technology Fund LLC - Series 1854
Raised
$556K
Investors
8
Min Invest
$4,993
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1854 is a pooled investment vehicle filed by EquityZen Advisors LLC and Philip Haslett that raised $556K from 8 investors with a $5K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. This is part of EquityZen's pre-IPO investment platform, which operates over 1,800 related series vehicles providing access to private growth companies.
This pre-IPO fund follows the standard EquityZen platform structure using dual 506(b) and 3(c)(1) exemptions with a retail-accessible $5K minimum. The raise size and investor count align with typical single-company SPV offerings in the secondary private market access category.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.